3-Oxopropyl propanoate | 63309-45-5

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 3-Oxopropyl propanoate
• CAS: 63309-45-5
• 化学式: C₆H₁₀O₃
• 分子量: 130.144
• InChiKey: VRRVETKCDNFOPH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  9
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  43.4
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  3-(7-oxocyclohepta-1,3,5-trien-1-yl)oxypropyl propanoate 生成 3-Oxopropyl propanoate
  参考文献：
  名称：

  TAKESHITA, HITOSHI;MAMETSUKA, HIROAKI;MATSUO, NORIHIDE, BULL. CHEM. SOC. JAP., 1982, 55, N 4, 1137-1139

  摘要：

  DOI：

文献信息

• Highly Enantioselective Hydroformylation of Olefins Catalyzed by Rhodium(I) Complexes of New Chiral Phosphine−Phosphite Ligands
  作者：Kyoko Nozaki、Nozomu Sakai、Tetsuo Nanno、Takanori Higashijima、Satoshi Mano、Toshihide Horiuchi、Hidemasa Takaya

  DOI：10.1021/ja970049d

  日期：1997.5.1

  1‘-binaphthalen-2‘-yl (S)-1,1‘-binaphthalene-2,2‘-diyl phosphite [(R,S)-BINAPHOS, (R,S)-2a], was synthesized. Its Rh(I) complex was prepared, and its structure has been characterized by 1H and 31P NMR spectroscopy. Using Rh(I) complexes of (R,S)-2a and its enantiomer, highly enantioselective hydroformylation of styrene has been performed (94% ee, iso/normal = 88/12). The catalyst system was also effective

  一种新的手性膦-亚磷酸酯配体，(R)-2-(diphenylphosphino)-1,1'-binaphthalen-2'-yl (S)-1,1'-binaphthalene-2,2'-diyl phosphite [(R ,S)-BINAPHOS, (R,S)-2a]，合成。制备了其Rh(I)配合物，并通过1H和31P NMR光谱对其结构进行了表征。使用 (R,S)-2a 及其对映异构体的 Rh(I) 配合物，已经进行了苯乙烯的高度对映选择性加氢甲酰化 (94% ee, 异/正 = 88/12)。该催化剂体系对多种其他烯烃也有效。其他一些带有 1,1'-联萘和联苯骨架的膦-亚磷酸酯配体，例如 (S)-3,3'-dichloro-6-(diphenylphosphino)-2,2',4,4'-tetramethylbiphenyl-6' -yl (R)-1,1'-联萘-2,2'-二基亚磷酸酯
• Beta-alanine derivatives and their use as receptor anatgonists
  申请人：——

  公开号：US20030018193A1

  公开（公告）日：2003-01-23

  A beta-alanine derivative of the formula (I) wherein R 1 is hydrogen atom or an amino protective group; A is a lower alkylene group or a lower alkenylene group; R 2 is hydrogen atom or an amino group which may be substituted with an acyl group; R 3 is hydrogen atom or an aryl or aralkyl group which may be substituted with one or more of hydroxy and/or lower alkoxy, a moiety represented by the formula (II), which is a bivalent N-containing 6- to 8-membered heterocyclic group, or a pharmaceutically acceptable salt thereof.

  公式（I）的β-丙氨酸衍生物，其中R1是氢原子或氨基保护基团；A是较低的烷基或较低的烯基基团；R2是氢原子或氨基团，可能被酰基取代；R3是氢原子或芳基或芳基基团，可能被一个或多个羟基和/或较低的烷氧基取代，由公式（II）表示的基团，该基团是一种双价的含氮6-到8-成员杂环基团，或其药用盐。
• Asymmetric Hydroformylation of Heterocyclic Olefins Mediated by Supramolecularly Regulated Rhodium-Bisphosphite Complexes
  作者：Laura Rovira、Mónica Vaquero、Anton Vidal-Ferran

  DOI：10.1021/acs.joc.5b01805

  日期：2015.10.16

  Rhodium complexes derived from conformationally transformable α,ω-bisphosphite ligands combined with a suitable alkali metal BArF salt as a regulation agent (RA) provide high regio- and enantioselectivities in the asymmetric hydroformylation (AHF) of three heterocyclic olefins. The outcome of the AHF could be exquisitely regulated by choosing the appropriate RA with an increase in the ee, the reversal

  衍生自构象可转化的α，ω-亚磷酸酯配体的铑配合物与合适的碱金属BArF盐作为调节剂（RA）结合，可在三种杂环烯烃的不对称加氢甲酰化（AHF）中提供较高的区域和对映选择性。通过选择适当的RA并增加ee，逆转区域选择性或完全抑制一种副产物，可以精确地调节AHF的结果。
• Benzoheterocyclic derivatives
  申请人：——

  公开号：US20020049194A1

  公开（公告）日：2002-04-25

  A benzoheterocyclic derivative of the following formula [1]: 1 and pharmaceutically acceptable salts thereof, which show excellent anti-vasopressin activity, vasopressin agonistic activity and oxytocin antagonistic activity, and are useful as a vasopressin antagonist, vasopressin agonist or oxytocin antagonist.

  以下式子所示的苯并杂环衍生物[1]及其药学上可接受的盐，展示出优异的抗加压素活性、加压素激动活性和催产素拮抗活性，可用作加压素拮抗剂、加压素激动剂或催产素拮抗剂。
• New Benzazole compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
  申请人：FUJISAWA PHARMACEUTICAL CO., LTD.

  公开号：EP0356234A2

  公开（公告）日：1990-02-28

  A compound of the formula : wherein R¹ is aryl or a heterocyclic group, each of which may have suitable sub­stituent(s), R² is hydroxy, mercapto, lower alkylthio, sulfo, lower alkyl, amino or sub­stituted amino, R³ is hydrogen, halogen or lower alkoxy, A is lower alkenylene, lower alkylene optionally substituted with hydroxy, or a group of the formula : -A′-Q-A˝-, in which A′ is lower alkylene, A˝ is lower alkylene or a single bond, and Q is O or S, and X is O, S, NH or N-R⁴, in which R⁴ is lower alkyl, and a pharmaceutically acceptable salt thereof. A process for preparing the benzazole compounds is also described, together with a pharmaceutical composition comprising the same as an active ingredient. The compounds exhibit anti-ulcer activity and H2 - receptor antagonism, and are therfore useful in the treatment of, for example, gastritis, ulcers, zollinger-ellison syndrome, oesophagitis and upper gastrointestinal bleeding.

  式中的化合物 其中 R¹ 是芳基或杂环基团，每个芳基或杂环基团可有适当的取代基、 R² 是羟基、巯基、低级烷硫基、磺基、低级烷基、氨基或取代氨基、 R³ 是氢、卤素或低级烷氧基、 A 是低级烯基、任选被羟基取代的低级烯基或式中的一个基团： -A′-Q-A˝-、 其中 A′是低级亚烷基，A˝是低级亚烷基或单键，Q 是 O 或 S，以及 X 是 O、S、NH 或 N-R⁴，其中 R⁴ 是低级烷基、 及其药学上可接受的盐。 此外，还描述了制备苯甲唑化合物的工艺，以及包含苯甲唑化合物作为活性成分的药物组合物。 这些化合物具有抗溃疡活性和 H2 受体拮抗作用，因此可用于治疗胃炎、溃疡、卓-艾综合征、食道炎和上消化道出血等疾病。